Panel Discussion | Should All High-Risk PCI Consider MCS?

Sunday, February 26, 2023

12:19 PM – 12:30 PM ET

Panel Moderator(s)

Rasha Al-Lamee, MA, MD, PhD

Interventional Cardiology Consultant
Imperial College London
London, England, United Kingdom

Disclosure(s): Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)
Maurice Buchbinder, MD, FSCAI

Medical Director
Foundation for Cardiovascular Medicine
San Diego, California, United States

No relationships to disclose
Rani K. Hasan, MD MHS

Assistant Professor of Medicine
Johns Hopkins University , Maryland, United States

Disclosure(s): No financial relationships to disclose
John P. Reilly, MD

Chief of Cardiology
Stony Brook Southampton Hospital
Stony Brook, New York, United States

No relationships to disclose

Panel Discussant(s)

J. Dawn Abbott, MD

Director, Interventional Cardiology at the Lifespan Cardiovascular Institute Director, Cardiac Catheterization Laboratories at Rhode Island and The Miriam Associate Chief, Faculty Development and Academic Advancement Professor of Medicine ,Warren Alpert Medical School, Brown University
Brown University
Providence, Rhode Island, United States

Disclosure(s): Abbott: Consultant (Ongoing); Accumed Radial Systems: Stock-privately held company (Ongoing); Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Medtronic: Advisor (Ongoing); Microport: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Penumbra: Consulting fees or other remuneration (Ongoing); Philips: Consultant/Advisory Board (Ongoing); Rapid AI: Consultant (Ongoing); Shockwave: Consulting fees or other remuneration (Ongoing)
Ion S. Jovin, MD

Professor
Virginia Commonwealth University/McGuire VAMC
Richmond, Virginia, United States

No relationships to disclose
ML

Michael S. Lee, MD, FACC, FSCAI

Interventional Cardiologist
UCLA School of Medicine
LOS ANGELES, California, United States

No relationships to disclose
Marie-Claude Morice, MD, FACC, FESC (she/her/hers)

CEO
ICPS, Ramsay, Générale de santé and ICERC Massy France
Massy, France

Disclosure(s): CERC ( centre european of cardiovascular research): Board Member/Officer/Trustee (Ongoing), Major Stockholder (not including mutual funds) (Ongoing), Officer or Board Member (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing), Salary (Ongoing); ELECTRODUCER: Stock Shareholder (excluding mutual funds) (Ongoing)
Natalia Pinilla, MD, PhD (she/her/hers)

Assistant Professor / Interventional Cardiologist
McMaster University
Burlington, Ontario, Canada

Disclosure(s): Abbott: Advisory Committee/Board Member (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Educational Grant (Ongoing); Amgen: Consultant (Ongoing); Conavi: Consultant (Ongoing); Novartis: Consultant (Ongoing); Philips: Advisory Committee/Board Member (Ongoing)
Samin K. Sharma, MD

Senior Vice-President, Operations & Quality
Mount Sinai Hospital
New York, New York, United States

No relationships to disclose
On Topaz, FACC, FSCAI,FACP (he/him/his)

Professor of Medicine ,Duke University School of Medicine.Chief, Division of Cardiology, Charles George veterans Affairs Medical Center, Asheville,, North Carolina
Duke University School of Medici
Biltmore Lake, North Carolina, United States

Disclosure information not submitted.

Disclosure(s):

Rasha Al-Lamee, MA, MD, PhD: Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)

Rani K. Hasan, MD MHS: No financial relationships to disclose

J. Dawn Abbott, MD: Abbott: Consultant (Ongoing); Accumed Radial Systems: Stock-privately held company (Ongoing); Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Medtronic: Advisor (Ongoing); Microport: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Penumbra: Consulting fees or other remuneration (Ongoing); Philips: Consultant/Advisory Board (Ongoing); Rapid AI: Consultant (Ongoing); Shockwave: Consulting fees or other remuneration (Ongoing)

Marie-Claude Morice, MD, FACC, FESC: CERC ( centre european of cardiovascular research): Board Member/Officer/Trustee (Ongoing), Major Stockholder (not including mutual funds) (Ongoing), Officer or Board Member (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing), Salary (Ongoing); ELECTRODUCER: Stock Shareholder (excluding mutual funds) (Ongoing)

Natalia Pinilla, MD, PhD: Abbott: Advisory Committee/Board Member (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Educational Grant (Ongoing); Amgen: Consultant (Ongoing); Conavi: Consultant (Ongoing); Novartis: Consultant (Ongoing); Philips: Advisory Committee/Board Member (Ongoing)